News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Sperzel John J III
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/09/2023 |
4
| Sperzel John J III (Chairman and CEO) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Sold 6,875 shares
@ $0.65, valued at
$4.5k
Exercised 6,667 shares
@ $0
Sold 2,898 shares
@ $0.59, valued at
$1.7k
Exercised 16,000 restricted stock units
@ $0
Exercised 6,667 restricted stock units
@ $0 |
|
| 04/11/2022 |
4
| Sperzel John J III (Chairman, CEO, and President) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Bought 30,000 shares
@ $0.5, valued at
$15k
|
|
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Sperzel John J III (See Remarks) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Granted 2,400,000 restricted stock units
@ $0 |
|
| 03/19/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2020 |
3
| Sperzel John J III (See Remarks) has filed a Form 3 on T2 Biosystems, Inc. |
| 06/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|